Unexplained weight loss (UWL), defined as a loss of more than 5% of the patient's body weight over a period of 6-12 months without a known cause, is a common yet challenging presentation in clinical practice. It can be an indicator of several underlying conditions, ranging from malignancies and endocrine disorders to psychiatric illnesses. This article aims to provide a comprehensive approach to evaluating and managing UWL.
The evaluation of UWL should be systematic and thorough. A detailed history, physical examination, and basic laboratory tests can identify a cause in about half of the cases. The history should focus on dietary intake, physical activity, changes in taste or smell, gastrointestinal symptoms, and psychosocial factors. The physical examination should include a comprehensive evaluation of all systems, with special attention to signs of malignancy, endocrine disorders, and malabsorption.
If the initial evaluation does not reveal a cause, further laboratory and imaging studies should be considered based on the patient's history and physical examination. Commonly used tests include complete blood count, metabolic panel, thyroid function tests, HIV testing, and imaging studies like a chest X-ray or abdominal ultrasound. Endoscopy and biopsy may be necessary in some cases.
Management of UWL depends on the underlying cause. If a specific disease is identified, treatment should be directed towards it. If no cause is found, the patient should be reassured and monitored closely for the development of new symptoms or signs. Nutritional support and psychological counseling may be beneficial in some cases.
Unexplained weight loss is a complex clinical problem that demands a comprehensive and systematic approach. While it can be a sign of serious underlying disease, a thorough evaluation often leads to the identification of a treatable cause. Close follow-up is crucial in cases where no cause is found, as new symptoms or signs may emerge over time.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation